369 related articles for article (PubMed ID: 11108147)
21. Nuclear factor-kappaB signaling contributes to severe, but not moderate, angiotensin II-induced left ventricular remodeling.
Sármán B; Skoumal R; Leskinen H; Rysä J; Ilves M; Soini Y; Tuukkanen J; Pikkarainen S; Lakó-Futó Z; Sármán B; Papp L; deChâtel R; Tóth M; Ruskoaho H; Szokodi I
J Hypertens; 2007 Sep; 25(9):1927-39. PubMed ID: 17762659
[TBL] [Abstract][Full Text] [Related]
22. Tetramethylpyrazine inhibits angiotensin II-induced cardiomyocyte hypertrophy and tumor necrosis factor-α secretion through an NF-κB-dependent mechanism.
Yu L; She T; Li M; Shi C; Han L; Cheng M
Int J Mol Med; 2013 Sep; 32(3):717-22. PubMed ID: 23842595
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin II induces nuclear factor- kappa B activation in cultured neonatal rat cardiomyocytes through protein kinase C signaling pathway.
Rouet-Benzineb P; Gontero B; Dreyfus P; Lafuma C
J Mol Cell Cardiol; 2000 Oct; 32(10):1767-78. PubMed ID: 11013121
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin II activates the proinflammatory transcription factor nuclear factor-kappaB in human monocytes.
Kranzhöfer R; Browatzki M; Schmidt J; Kübler W
Biochem Biophys Res Commun; 1999 Apr; 257(3):826-8. PubMed ID: 10208867
[TBL] [Abstract][Full Text] [Related]
25. Effect of NF-kappaB on the induction of PDGF-B transcription by angiotensin II in the ECV304 cell line.
Li H; Yin H; Zhang H; Cao X; Wang Z; She M
Chin Med J (Engl); 2002 Mar; 115(3):433-8. PubMed ID: 11940383
[TBL] [Abstract][Full Text] [Related]
26. Tetramethylpyrazine inhibits agiontensin II-induced nuclear factor-kappaB activation and bone morphogenetic protein-2 downregulation in rat vascular smooth muscle cells.
Ren XY; Ruan QR; Zhu DH; Zhu M; Qu ZL; Lu J
Sheng Li Xue Bao; 2007 Jun; 59(3):339-44. PubMed ID: 17579790
[TBL] [Abstract][Full Text] [Related]
27. Mechanism of induction of muscle protein degradation by angiotensin II.
Russell ST; Wyke SM; Tisdale MJ
Cell Signal; 2006 Jul; 18(7):1087-96. PubMed ID: 16257180
[TBL] [Abstract][Full Text] [Related]
28. Cooperation of SRC-1 and p300 with NF-kappaB and CREB in angiotensin II-induced IL-6 expression in vascular smooth muscle cells.
Sahar S; Reddy MA; Wong C; Meng L; Wang M; Natarajan R
Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1528-34. PubMed ID: 17495236
[TBL] [Abstract][Full Text] [Related]
29. Angiotensin II, via angiotensin receptor type 1/nuclear factor-κB activation, causes a synergistic effect on interleukin-1-β-induced inflammatory responses in cultured mesangial cells.
Alique M; Sánchez-López E; Rayego-Mateos S; Egido J; Ortiz A; Ruiz-Ortega M
J Renin Angiotensin Aldosterone Syst; 2015 Mar; 16(1):23-32. PubMed ID: 25354522
[TBL] [Abstract][Full Text] [Related]
30. Regulation of inhibitory protein-kappaB and monocyte chemoattractant protein-1 by angiotensin II type 2 receptor-activated Src homology protein tyrosine phosphatase-1 in fetal vascular smooth muscle cells.
Wu L; Iwai M; Li Z; Shiuchi T; Min LJ; Cui TX; Li JM; Okumura M; Nahmias C; Horiuchi M
Mol Endocrinol; 2004 Mar; 18(3):666-78. PubMed ID: 14684844
[TBL] [Abstract][Full Text] [Related]
31. Angiotensin II induces NF-kappa B activation in HUVEC via the p38MAPK pathway.
Guo RW; Yang LX; Li MQ; Liu B; Wang XM
Peptides; 2006 Dec; 27(12):3269-75. PubMed ID: 17097193
[TBL] [Abstract][Full Text] [Related]
32. Angiotensin III increases MCP-1 and activates NF-kappaB and AP-1 in cultured mesangial and mononuclear cells.
Ruiz-Ortega M; Lorenzo O; Egido J
Kidney Int; 2000 Jun; 57(6):2285-98. PubMed ID: 10844599
[TBL] [Abstract][Full Text] [Related]
33. Hyperglycemia enhances VSMC proliferation with NF-kappaB activation by angiotensin II and E2F-1 augmentation by growth factors.
Fujita N; Furukawa Y; Du J; Itabashi N; Fujisawa G; Okada K; Saito T; Ishibashi S
Mol Cell Endocrinol; 2002 Jun; 192(1-2):75-84. PubMed ID: 12088869
[TBL] [Abstract][Full Text] [Related]
34. Effects of central injection of angiotensin-converting-enzyme inhibitor and angiotensin type 1 receptor antagonist on the brain NF-kappaB and AP-1 activities of rats given LPS.
Watanabe K; Taniguchi M; Miyoshi M; Shimizu H; Imoto T; Sato K; Watanabe T
Peptides; 2006 Jun; 27(6):1538-46. PubMed ID: 16356591
[TBL] [Abstract][Full Text] [Related]
35. Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways.
Li HL; Wang AB; Huang Y; Liu DP; Wei C; Williams GM; Zhang CN; Liu G; Liu YQ; Hao DL; Hui RT; Lin M; Liang CC
Free Radic Biol Med; 2005 Jan; 38(2):243-57. PubMed ID: 15607907
[TBL] [Abstract][Full Text] [Related]
36. Endoplasmic reticulum and oxidant stress mediate nuclear factor-κB activation in the subfornical organ during angiotensin II hypertension.
Young CN; Li A; Dong FN; Horwath JA; Clark CG; Davisson RL
Am J Physiol Cell Physiol; 2015 May; 308(10):C803-12. PubMed ID: 25980014
[TBL] [Abstract][Full Text] [Related]
37. Vascular inflammation and the renin-angiotensin system.
Brasier AR; Recinos A; Eledrisi MS
Arterioscler Thromb Vasc Biol; 2002 Aug; 22(8):1257-66. PubMed ID: 12171785
[TBL] [Abstract][Full Text] [Related]
38. Regulation of Angiotensin II receptor signaling by cysteine modification of NF-κB.
Nishida M; Kitajima N; Saiki S; Nakaya M; Kurose H
Nitric Oxide; 2011 Aug; 25(2):112-7. PubMed ID: 21078404
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin II stimulates matrix metalloproteinase secretion in human vascular smooth muscle cells via nuclear factor-kappaB and activator protein 1 in a redox-sensitive manner.
Browatzki M; Larsen D; Pfeiffer CA; Gehrke SG; Schmidt J; Kranzhofer A; Katus HA; Kranzhofer R
J Vasc Res; 2005; 42(5):415-23. PubMed ID: 16103692
[TBL] [Abstract][Full Text] [Related]
40. Angiotensin II induces tumor necrosis factor biosynthesis in the adult mammalian heart through a protein kinase C-dependent pathway.
Kalra D; Sivasubramanian N; Mann DL
Circulation; 2002 May; 105(18):2198-205. PubMed ID: 11994255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
